Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheney J G Drew

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
International Review of Neurobiology|November 24, 2022
Considerations for clinical trial design and conduct in the evaluation of novel advanced therapeutics in neurodegenerative diseaseCheney J G Drew, Monica Busse
Advances in Protein Chemistry and Structural Biology|October 11, 2012
Next generation sequencing in the clinical domain: clinical advantages, practical, and ethical challengesRose Thompson, Cheney J G Drew, Rhys H Thomas
International Review of Neurobiology|November 24, 2022
PrefaceEmma L Lane, Cheney J G Drew, Mariah J Lelos
Brain Research Bulletin|November 18, 2008
The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor functionPatrick N Pallier, Cheney J G Drew, A Jennifer Morton
Human Molecular Genetics|July 27, 2007
Complexin 1 knockout mice exhibit marked deficits in social behaviours but appear to be cognitively normalCheney J G Drew, Rachel J Kyd, A Jennifer Morton
Journal of Huntington'S Disease|July 27, 2014
Direct Visualisation of Abnormal Dendritic Spine Morphology in the Hippocampus of the R6/2 Transgenic Mouse Model of Huntington's DiseaseSimon J Bulley, Cheney J G Drew, A Jennifer Morton
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 5, 2009
Chronic treatment with 13-cis-retinoic acid changes aggressive behaviours in the resident-intruder paradigm in ratsSimon Trent, Cheney J G Drew, Paul J Mitchell, et al.
Journal of the Intensive Care Society|September 30, 2025
Critical illness and recovery-learning from the shared experience of survivors and their families: A qualitative studyCeri Lynch, Cheney J G Drew, Sarah Gill, et al.
Trials|November 19, 2016
Integrating technology into complex intervention trial processes: a case studyCheney J G Drew, Vincent Poile, Rob Trubey, et al.
BMJ Open|August 13, 2025
VR READY: a protocol for a non-randomised, single-arm, mixed methods, feasibility trial of a coproduced <i>V</i>i<i>R</i>tual <i>RE</i>ality intervention to <i>A</i>i<i>D</i> recover<i>Y</i> in people recently admitted to intensive careCheney J G Drew, Kim Smallman, Sarah Gill, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
International Review of Neurobiology|November 24, 2022
Considerations for clinical trial design and conduct in the evaluation of novel advanced therapeutics in neurodegenerative diseaseCheney J G Drew, Monica Busse
Advances in Protein Chemistry and Structural Biology|October 11, 2012
Next generation sequencing in the clinical domain: clinical advantages, practical, and ethical challengesRose Thompson, Cheney J G Drew, Rhys H Thomas
International Review of Neurobiology|November 24, 2022
PrefaceEmma L Lane, Cheney J G Drew, Mariah J Lelos
Brain Research Bulletin|November 18, 2008
The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor functionPatrick N Pallier, Cheney J G Drew, A Jennifer Morton
Human Molecular Genetics|July 27, 2007
Complexin 1 knockout mice exhibit marked deficits in social behaviours but appear to be cognitively normalCheney J G Drew, Rachel J Kyd, A Jennifer Morton
Journal of Huntington'S Disease|July 27, 2014
Direct Visualisation of Abnormal Dendritic Spine Morphology in the Hippocampus of the R6/2 Transgenic Mouse Model of Huntington's DiseaseSimon J Bulley, Cheney J G Drew, A Jennifer Morton
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 5, 2009
Chronic treatment with 13-cis-retinoic acid changes aggressive behaviours in the resident-intruder paradigm in ratsSimon Trent, Cheney J G Drew, Paul J Mitchell, et al.
Journal of the Intensive Care Society|September 30, 2025
Critical illness and recovery-learning from the shared experience of survivors and their families: A qualitative studyCeri Lynch, Cheney J G Drew, Sarah Gill, et al.
Trials|November 19, 2016
Integrating technology into complex intervention trial processes: a case studyCheney J G Drew, Vincent Poile, Rob Trubey, et al.
BMJ Open|August 13, 2025
VR READY: a protocol for a non-randomised, single-arm, mixed methods, feasibility trial of a coproduced <i>V</i>i<i>R</i>tual <i>RE</i>ality intervention to <i>A</i>i<i>D</i> recover<i>Y</i> in people recently admitted to intensive careCheney J G Drew, Kim Smallman, Sarah Gill, et al.
Pageof 3